TABLE 2.
Number of “Meta-Genes” and Enriched Gene Sets in Experimental Subgroups and Number of Contrasts and Studies Contributing to the Subgroup
| Category | Group | Genes |
Gene sets |
Number of Contrasts | Number of Studies | ||
|---|---|---|---|---|---|---|---|
| Up | Down | Up | Down | ||||
| Time | Early | 164 | 413 | 75 | 62 | 14 | 6 |
| Middle | 177 | 209 | 4 | 7 | 15 | 7 | |
| Late | 12 | 12 | 0 | 0 | 21 | 8 | |
| Mode of action | Reactive | 28 | 15 | 5 | 1 | 6 | 5 |
| Endocrine | 126 | 249 | 0 | 1 | 13 | 6 | |
| Neuroactive | 120 | 168 | 4 | 32 | 7 | 3 | |
| Concentration | No effect | 11 | 14 | 2 | 0 | 16 | 5 |
| LOEC | 411 | 531 | 0 | 21 | 15 | 5 | |
| EC | 151 | 327 | 11 | 35 | 21 | 9 | |
| All | All | 4 | 7 | 17 | 1 | 45 | 17 |